<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(1)</volume><submitter>Singkham-In U</submitter><funding>Ratchadapisek Somphot Fund for Postdoctoral Fellowship</funding><funding>90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksompot Endowment Fund) from Graduate School</funding><pubmed_abstract>The carbapenem-resistant Acinetobacter calcoaceticus-baumannii (ACB) complex has become an urgent threat worldwide. Here, we determined antibiotic combinations and the feasible synergistic mechanisms against three couples of ACB (A. baumannii (AB250 and A10), A. pittii (AP1 and AP23), and A. nosocomialis (AN4 and AN12)). Imipenem with fosfomycin, the most effective in the time-killing assay, exhibited synergism to all strains except AB250. MurA, a fosfomycin target encoding the first enzyme in the de novo cell wall synthesis, was observed with the wild-type form in all isolates. Fosfomycin did not upregulate murA, indicating the MurA-independent pathway (cell wall recycling) presenting in all strains. Fosfomycin more upregulated the recycling route in synergistic strain (A10) than non-syne</pubmed_abstract><journal>Scientific reports</journal><pagination>230</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8741973</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Synergism of imipenem with fosfomycin associated with the active cell wall recycling and heteroresistance in Acinetobacter calcoaceticus-baumannii complex.</pubmed_title><pmcid>PMC8741973</pmcid><pubmed_authors>Singkham-In U</pubmed_authors><pubmed_authors>Chatsuwan T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synergism of imipenem with fosfomycin associated with the active cell wall recycling and heteroresistance in Acinetobacter calcoaceticus-baumannii complex.</name><description>The carbapenem-resistant Acinetobacter calcoaceticus-baumannii (ACB) complex has become an urgent threat worldwide. Here, we determined antibiotic combinations and the feasible synergistic mechanisms against three couples of ACB (A. baumannii (AB250 and A10), A. pittii (AP1 and AP23), and A. nosocomialis (AN4 and AN12)). Imipenem with fosfomycin, the most effective in the time-killing assay, exhibited synergism to all strains except AB250. MurA, a fosfomycin target encoding the first enzyme in the de novo cell wall synthesis, was observed with the wild-type form in all isolates. Fosfomycin did not upregulate murA, indicating the MurA-independent pathway (cell wall recycling) presenting in all strains. Fosfomycin more upregulated the recycling route in synergistic strain (A10) than non-syne</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2025-04-18T17:08:46.297Z</modification><creation>2022-02-11T15:08:32.947Z</creation></dates><accession>S-EPMC8741973</accession><cross_references><pubmed>34997148</pubmed><doi>10.1038/s41598-021-04303-7</doi></cross_references></HashMap>